Enlivex Ltd (ENLV) Options Open Interest

Monitoring ENLV open interest helps you see where real money is positioned on Enlivex Ltd's options and which strikes are attracting the most commitment from traders. Enlivex Ltd's open interest reflects the total number of outstanding contracts that have not been closed or exercised, making it a powerful gauge of liquidity, conviction, and potential support and resistance zones. Use our scanner to monitor ENLV options open interest in real time and find the strikes that matter.

Open interest is distinct from volume: volume counts how many contracts are traded in a session, while open interest counts how many remain open at the end of the day. Rising ENLV options open interest alongside rising volume suggests new positions are being built, while falling open interest signals positions are being closed. Heavy open interest at specific strikes often acts as a magnet near expiration and can hint at where dealers and large traders expect Enlivex Ltd to settle.

Enlivex Therapeutics Ltd. operates as a clinical-stage macrophage reprogramming immunotherapy company. It is developing Allocetra, a cell-based therapy to treat organ dysfunction and failure associated with sepsis that is in phase II clinical trial, as well as in preclinical trial to treat solid tumors. Enlivex Therapeutics Ltd. was founded in 2005 and is headquartered in Nes Ziona, Israel.

Pin risk into expiration, dealer positioning, liquidity checks for large orders — all of it starts with knowing where ENLV open interest is concentrated. Our scanner maps Enlivex Ltd's open interest across every strike and expiry, flags unusual buildups, and lets you drill into the contracts that institutional money is actually holding. Trade Enlivex Ltd's options open interest as the signal it is, not as an afterthought.